The largest database of trusted experimental protocols

125 protocols using z vad fmk

1

Rat Ovary Transplantation Preservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We examined how long ovaries removed from a living body remain ready for transplantation using rat ovaries. As donor rats, slc: SD female rats, homebred and Crl: CD rats purchased from Jackson Laboratory Japan, aged over 8 weeks were used (n = 15). They were anesthetized with CO2 inhalation and euthanized by cervical dislocation, then ovaries were removed. The removed left and right ovaries were each divided into four equal portions and stored in tissue preservation solution Lifor (Lifeblood Medical Inc., NJ, USA). During storage, they were kept at 4 °C in a tissue transport kit (CARD refrigerated transport kit, Kyudo Company, Japan), assuming marmoset ovary transport. The ovaries were implanted under the renal capsule of nude mice at 0, 1, 2, 3, and 4 days after the storage.
For ovarian protection experiments, Z-VAD-FMK (Caspase Inhibitor Z-VAD-FMK; G7231, Promega, USA) was added to Lifor (final concentration: 50 µM).
+ Open protocol
+ Expand
2

TNFα-Induced Cell Death Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant TNFα (R&D Systems) was used at various concentrations as indicated in the results section and figure legends. For TNFα neutralizing experiments, a goat IgG anti-TNFα neutralizing antibody (10.0 μg/ml, R&D Systems, AF-410-NA) 30 (link) was incubated with conditioned medium for 1 hour prior to treatment of cells along with control conditions using a goat IgG isotype control (10.0 μg/ml, R&D Systems, AB-108-C). Z-VAD.fmk (Promega; Madison, WI, USA) was used at a concentration of 40 μM.31 (link) Z-VAD.fmk was added to primary culture at the same time as TNFα and incubated with the ICC for a total of 24 hours. Necrostatin-1 (nec-1) in both active and inactive (Millipore) forms was used at a concentration of 30 μM.32 (link), 33 (link) Nec-1 was added to ICC primary cultures 1 hour before the addition of TNFα and incubated with ICC for a total of 24 hours.
+ Open protocol
+ Expand
3

Evaluating Cytotoxicity and Cell Viability with LDH and CCK-8

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity and cell viability were measured by lactate dehydrogenase (LDH) cytotoxicity assay (TaKaRa, Shiga, Japan) and cell counting kit (CCK)-8 (Dojindo Laboratories, Kumamoto, Japan), respectively, by following the manufacturer’s instructions. The cells were treated with 2% Triton X-100 as a positive control for the LDH cytotoxicity assay. The cells were then seeded at a density of 1 × 104 cells/well in a 96-well cell culture plate in 10% FBS Ham’s F-12 K medium. After 24 h of incubation, the cells were treated with different concentrations of NYT in 1% FBS Ham’s F-12 K medium for 24 h, and then 5% CSE with NYT was added. After 24 h of incubation, the cell culture plates were centrifuged at 250 g for 10 min, and the supernatant was collected for performing the LDH assay. The LDH cytotoxicity assay kit was used to examine the level of LDH release, and the optical density of the samples was measured using a microplate reader Synergy H1 (BioTek, Tokyo, Japan) at 490 nm. CCK-8 was used to examine the cell viability, and the optical density was measured using a microplate reader set at 450 nm. To investigate the type of cell death that was induced by CSE exposure, the cells were treated with Z-VAD-FMK (Promega, Madison, WI, USA) or necrostatin-1 (Sellmeck Chemical, Houston, TX, USA) 2 h before the CSE exposure.
+ Open protocol
+ Expand
4

Mitochondrial Dysfunction Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the following reagents: NAC, GSH (Sigma Chemical Corp.); MitoTracker Green, calcein acetoxymethyl ester (calcein-AM), ethidium homodimer (EthD-1), 5,6-carboxy-2′,7′-dichlorofluorescein diacetate (H2DCF-DA), MitoSOX red, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolylcarbocyanine chloride (JC-1; Invitrogen); z-VAD-fmk (Promega); MnTBAP (Mn[III] tetrakis[benzoic acid porphyrin]; Calbiochem). We used antibodies against β-actin (Santa Cruz Biotechnology, Inc. and Abcam), Flag-M2 (Sigma), caspase-3, caspase-8 (Cell Signaling Technology), Bcl-2 (Santa Cruz), poly(ADPribose) polymerase (BD Pharmingen), p53 (Cell Signaling Technology and Santa Cruz) and horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse IgG antibodies (Zymed).
+ Open protocol
+ Expand
5

Evaluating Apoptosis Signaling in Pituitary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents and chemicals were used in the present study: RE (Sigma, St. Louis, MO, USA); 17β-estradiol (E2; Sigma); general caspase inhibitor z-VAD-fmk (Promega Corporation, Madison, WI, USA); and antibodies against rat PRL (rPRL; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), GH (Chemicon, Temecula, CA, USA), poly ADP ribose polymerase (PARP; Invitrogen Life Technologies, Carlsbad, CA, USA) and caspase-3 and -8 (Santa Cruz Biotechnology, Inc.).
+ Open protocol
+ Expand
6

Quantifying ROS-induced DNA Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated in growth medium containing 2.5 μM CellRox Green reagent (Invitrogen, USA) for 30 min at 37 °C. ROS levels were quantitated by measuring Mean Fluorescence Intensity (MFI) in individual cells using flow-cytometric analysis on a BD-Accuri flow cytometer using the C6 software. TBHP (tert-butyl hydroperoxide, 100 μM) (458149, Sigma, USA) was used as positive control. 2.5 mM NAC (N-acetylcysteine) (A9165, Sigma, USA) was used as a ROS scavenger for 30 min prior to TBHP treatment. ROS dependent DNA damage was measured by treating cells with 50 µM H2O2 for 30 min in the presence or absence of caspase inhibitor z-VAD-fmk (Promega, USA) or ROS scavenger NAC. The DNA damage was confirmed using western blotting with the anti-γH2AX antibody.
+ Open protocol
+ Expand
7

Molecular Analysis of Apoptosis Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The culture media and fetal bovine serum were purchased from Life Technologies (Grand Island, NY, USA). The antibodies against the following proteins were obtained from the indicated vendors: cleaved PARP (Asp214) and γH2AX (9718), (Cell Signaling Technology, Temecula, CA, USA); hnRNP A1 (F-8) and hnRNP A2 (EF-67) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA); TRF2 (Millipore, Billerica, MA, USA); β-actin (Sigma-Aldrich, St. Louis, MO, USA); MDC-1 (M2444) (Sigma-Aldrich); caspase-7 (9492), -8 (9746), and PARP (9542) (Cell Signaling Technology). The FITC 488–OO-(CCCTAA)3 PNA probe (F1009) was obtained from Panagene (Daejeon, Korea), and etoposide (E1383) was purchased from Sigma-Aldrich. Superscript III reverse transcriptase, TRIzol reagent, and antibiotics were obtained from Gibco-BRL (San Francisco, CA, USA). The broad-spectrum caspase inhibitor Z-VAD-FMK was purchased from Promega (Fitchburg, WI, USA). Gel electrophoresis reagents were obtained from Bio-Rad (Berkeley, CA, USA).
+ Open protocol
+ Expand
8

Sabutoclax and Minocycline Combination Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
For all in vitro studies, Sabutoclax (produced by Dr. Maurizio Pellecchia) was diluted in DMSO and Minocycline (Sigma) in PBS. For combination treatments, Sabutoclax and Minocycline were administered to cells simultaneously. zVAD-FMK (20 μM, Promega) was incubated with cells for 1 hour prior to treatment with Sabutoclax and Minocycline. Caspase 8 specific inhibitor, z-IETD-FMK (20 μM, BD Pharmingen) was also incubated with cells for 1 hour before treatment with Sabutoclax and Minocycline.
+ Open protocol
+ Expand
9

BITC Cytotoxicity Assays with Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability following BITC treatment was assessed using the WST-1 reagent (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. The proliferation assays were performed using the following reagents: the ROS scavenger N-acetylcysteine (NAC) and catalase (CAT), the catalase inhibitor 3-Amino-1,2,4-triazole (3-AT), the autophagy inhibitors 3-methyladenine (3-MA) and bafilomycin A1 (Baf A1), and the broad-spectrum caspase inhibitor Z-VAD-FMK (Promega, Madison, WI, USA). The cells were pretreated with 10 mM NAC, 5,000 U/ml CAT, 1 or 10 mM 3-AT, 1 mM 3-MA, 200 mM Baf A1 or 20 μM Z-VAD-FMK for 2 hrs and then treated with BITC in the presence of the specified inhibitor for the indicated duration. Cell viability was determined as the percentage of the controls. Each condition was assessed in eight replicate wells, and the data were obtained from at least three separate experiments.
+ Open protocol
+ Expand
10

Apoptosis and Necroptosis Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium and DMEM, fetal bovine serum (FBS), glutamine, and a streptomycin/penicillin antibiotic solution were all purchased from Invitrogen. Bacterial lipopolysaccharide (LPS, Escherichia coli 026:B6) and staurosporine (STS)2 were purchased from Sigma. Ac-YVAD-CHO, IETD-CHO, cycloheximide (CHX), ALLN, calpain inhibitor III, EST, and PD150606 were purchased from Merck Chemicals, Ltd. CHX causes apoptosis by inhibiting protein translation and subsequently cell growth, whereas STS is a broad spectrum kinase inhibitor that induces apoptosis. Z-VAD-fmk was purchased from Promega. Necrostatin-1 was purchased from Sigma. The anti-mouse IL-1β and IL-1α antibodies were from R&D Systems. Secondary antibody HRP conjugates were from DAKO.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!